Also categorized in News:
Hebrew U tech chief seeks balance between academia and industry
x hide permanently

CIITECH Sponsors Research Project on Cannabis-based Therapy for Asthma at the Multidisciplinary

PR Newswire

LONDON and TEL AVIV, Israel, October 24, 2017 /PRNewswire/ 

CIITECH, a UK-Israel cannabis biotech startup, announced today that it has selected to sponsor a research project with the Multidisciplinary Center on Cannabinoid Research of the Hebrew University of Jerusalem, focused on the therapeutic benefit of cannabis for the treatment of asthma.

CIITECH selected to award research funding, through a non-exclusive grant competition, to the collaborative work of Professor Raphael Mechoulam, a pioneer in the field of cannabis research credited for the discovery of the endocannabinoid system, and his colleague, Professor Francesca Levi-Schaffer, a global expert in asthma research. Together, these ...

Mentions: Medicine/Health